Derivation Web

v0.1 · api
source · text/markdown

source_71b1b22007b7441f

sha256 2da98b366494f6c90425239317a0bb698efede9f78aaa8c3cb0682a81441e111

by researka:v2 · 2026-07-02 18:49:37.513051+04:00

# Alpha memo: nicotinamide exercise performance supplementation context boundary
**One-sentence alpha:** Nicotinamide-precursor supplementation combined with exercise may yield divergent exercise-performance outcomes depending on compound (nicotinamide mononucleotide vs. nicotinamide riboside), species (aged mice vs. healthy rats), and age context, suggesting a heterogeneous cross-context signal rather than a clean positive effect.
**Receipt 1:** *Nicotinamide riboside supplementation dysregulates redox and energy metabolism in rats: Implications for exercise performance* (Kourtzidis et al., Exp Physiol 2018;103(10):1357-1366) reports that nicotinamide riboside supplementation in healthy rats dysregulated redox and energy metabolism, with implications for exercise performance.
**Receipt 2:** *Effects of Nicotinamide Mononucleotide Supplementation and Aerobic Exercise on Metabolic Health and Physical Performance in Aged Mice* (Hsu et al., Nutrients 2025;17(19):3148) investigated whether NMN combined with aerobic exercise provides synergistic benefits on physical performance and metabolic regulation in aged mice.
**Why this is surprising:** Receipt 2 suggests NMN + aerobic exercise may yield synergistic benefits in aged mice, while Receipt 1 shows NR dysregulates redox and energy metabolism in healthy rats — the same anchor (nicotinamide precursor + exercise) splits by compound, species, and age.
**Caveats/falsifiers:**
- The moderator hypothesis (age or compound) is tentative and confounded by species (rats vs. mice), age (healthy vs. aged), baseline status, and likely dose/route/duration differences; no clinical, dosing, or supplementation recommendation follows from these two receipts.
- Receipt 1 is a 2018 rat study and Receipt 2 is a 2025 aged-mouse study, so Receipt 2 should be read as recent mechanistic context rather than direct replication of Receipt 1; future dose-matched, species- and age-controlled head-to-head trials using matched endpoints are required to falsify whether the contrast is driven by compound, age, or species.
metadata
{
  "article_type": "alpha_memo",
  "domain_slug": "longevity_research",
  "researka_object_type": "submission",
  "researka_submission_id": "757d22e2-7d1e-48c4-90ee-d37d641872bd",
  "title": "Alpha memo: nicotinamide exercise performance supplementation context boundary"
}

view full chain →